TP53 and neoplasm: By pinpointing and tracing cells after p53 LOH in premalignancy, we demonstrate that the evolution of malignant pancreatic genomes enabled by p53 disruption is not random; instead, it occurs through distinct, ordered phases that operate with predictive principles that can be linked to specific histological stages and contribute functionally to tumour progression.